Selected research
Industry Research
Recombinant Protein Production Service Industry Research Report 2026
Market perspective
The global Recombinant Protein Production Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Recombinant Protein Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Recombinant Protein Production Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Recombinant Protein Production Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Recombinant Protein Production Service include Charles River, Biomatik, R&D Systems, Applied Biological Materials Inc. (abm), VectorBuilder, BiologicsCorp, Proteos, RayBiotech and Leinco Technologies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Recombinant Protein Production Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Recombinant Protein Production Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Recombinant Protein Production Service Market by Company
Charles River
Biomatik
R&D Systems
Applied Biological Materials Inc. (abm)
VectorBuilder
BiologicsCorp
Proteos
RayBiotech
Leinco Technologies
Kinexus Bioinformatics
InVivo BioTech Services GmbH
Expression Systems
Creative Biolabs
G &P Biosciences
Eurofins Discovery
Levprot Bioscience
eEnzyme
NorthX Biologics
Jubilant Biosys
GenScript
Boster Bio
Sino Biological
WuXi Biologic
CUSABIO TECHNOLOGY
Recombinant Protein Production Service Segment by Type
Mammalian Cell Based
Bacteria Based
Insect Cell Based
Others
Recombinant Protein Production Service Segment by Application
Biomedicine
Industrial Biotechnology
Therapeutics
Others
Recombinant Protein Production Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Protein Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Protein Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Protein Production Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Recombinant Protein Production Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Recombinant Protein Production Service Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Recombinant Protein Production Service Revenue Market Share by Type (2021-2026)
Table 7. Global Recombinant Protein Production Service Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Recombinant Protein Production Service Revenue Market Share by Type (2027-2032)
Table 9. Global Recombinant Protein Production Service Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Recombinant Protein Production Service Revenue Market Share by Application (2021-2026)
Table 11. Global Recombinant Protein Production Service Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Recombinant Protein Production Service Revenue Market Share by Application (2027-2032)
Table 13. Global Recombinant Protein Production Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Recombinant Protein Production Service Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Recombinant Protein Production Service Market Share by Region (2021-2026)
Table 16. Global Recombinant Protein Production Service Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Recombinant Protein Production Service Market Share by Region (2027-2032)
Table 18. Recombinant Protein Production Service Industry Trends
Table 19. Recombinant Protein Production Service Industry Drivers
Table 20. Recombinant Protein Production Service Industry Opportunities and Challenges
Table 21. Recombinant Protein Production Service Market Restraints
Table 22. Global Top Recombinant Protein Production Service Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Recombinant Protein Production Service Revenue Market Share by Players (2021-2026)
Table 24. Global Recombinant Protein Production Service Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Recombinant Protein Production Service, Headquarters and Area Served
Table 26. Global Recombinant Protein Production Service Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Recombinant Protein Production Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Recombinant Protein Production Service Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Recombinant Protein Production Service Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Recombinant Protein Production Service Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Recombinant Protein Production Service Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Recombinant Protein Production Service Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Recombinant Protein Production Service Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Recombinant Protein Production Service Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Recombinant Protein Production Service Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Recombinant Protein Production Service Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Recombinant Protein Production Service Market Size by Country (2027-2032) & (US$ Million)
Table 45. Charles River Company Information
Table 46. Charles River Business Overview
Table 47. Charles River Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 48. Charles River Recombinant Protein Production Service Product Portfolio
Table 49. Charles River Recent Developments
Table 50. Biomatik Company Information
Table 51. Biomatik Business Overview
Table 52. Biomatik Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 53. Biomatik Recombinant Protein Production Service Product Portfolio
Table 54. Biomatik Recent Developments
Table 55. R&D Systems Company Information
Table 56. R&D Systems Business Overview
Table 57. R&D Systems Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 58. R&D Systems Recombinant Protein Production Service Product Portfolio
Table 59. R&D Systems Recent Developments
Table 60. Applied Biological Materials Inc. (abm) Company Information
Table 61. Applied Biological Materials Inc. (abm) Business Overview
Table 62. Applied Biological Materials Inc. (abm) Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 63. Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Product Portfolio
Table 64. Applied Biological Materials Inc. (abm) Recent Developments
Table 65. VectorBuilder Company Information
Table 66. VectorBuilder Business Overview
Table 67. VectorBuilder Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 68. VectorBuilder Recombinant Protein Production Service Product Portfolio
Table 69. VectorBuilder Recent Developments
Table 70. BiologicsCorp Company Information
Table 71. BiologicsCorp Business Overview
Table 72. BiologicsCorp Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 73. BiologicsCorp Recombinant Protein Production Service Product Portfolio
Table 74. BiologicsCorp Recent Developments
Table 75. Proteos Company Information
Table 76. Proteos Business Overview
Table 77. Proteos Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 78. Proteos Recombinant Protein Production Service Product Portfolio
Table 79. Proteos Recent Developments
Table 80. RayBiotech Company Information
Table 81. RayBiotech Business Overview
Table 82. RayBiotech Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 83. RayBiotech Recombinant Protein Production Service Product Portfolio
Table 84. RayBiotech Recent Developments
Table 85. Leinco Technologies Company Information
Table 86. Leinco Technologies Business Overview
Table 87. Leinco Technologies Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 88. Leinco Technologies Recombinant Protein Production Service Product Portfolio
Table 89. Leinco Technologies Recent Developments
Table 90. Kinexus Bioinformatics Company Information
Table 91. Kinexus Bioinformatics Business Overview
Table 92. Kinexus Bioinformatics Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 93. Kinexus Bioinformatics Recombinant Protein Production Service Product Portfolio
Table 94. Kinexus Bioinformatics Recent Developments
Table 95. InVivo BioTech Services GmbH Company Information
Table 96. InVivo BioTech Services GmbH Business Overview
Table 97. InVivo BioTech Services GmbH Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 98. InVivo BioTech Services GmbH Recombinant Protein Production Service Product Portfolio
Table 99. InVivo BioTech Services GmbH Recent Developments
Table 100. Expression Systems Company Information
Table 101. Expression Systems Business Overview
Table 102. Expression Systems Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 103. Expression Systems Recombinant Protein Production Service Product Portfolio
Table 104. Expression Systems Recent Developments
Table 105. Creative Biolabs Company Information
Table 106. Creative Biolabs Business Overview
Table 107. Creative Biolabs Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 108. Creative Biolabs Recombinant Protein Production Service Product Portfolio
Table 109. Creative Biolabs Recent Developments
Table 110. G &P Biosciences Company Information
Table 111. G &P Biosciences Business Overview
Table 112. G &P Biosciences Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 113. G &P Biosciences Recombinant Protein Production Service Product Portfolio
Table 114. G &P Biosciences Recent Developments
Table 115. Eurofins Discovery Company Information
Table 116. Eurofins Discovery Business Overview
Table 117. Eurofins Discovery Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 118. Eurofins Discovery Recombinant Protein Production Service Product Portfolio
Table 119. Eurofins Discovery Recent Developments
Table 120. Levprot Bioscience Company Information
Table 121. Levprot Bioscience Business Overview
Table 122. Levprot Bioscience Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 123. Levprot Bioscience Recombinant Protein Production Service Product Portfolio
Table 124. Levprot Bioscience Recent Developments
Table 125. eEnzyme Company Information
Table 126. eEnzyme Business Overview
Table 127. eEnzyme Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 128. eEnzyme Recombinant Protein Production Service Product Portfolio
Table 129. eEnzyme Recent Developments
Table 130. NorthX Biologics Company Information
Table 131. NorthX Biologics Business Overview
Table 132. NorthX Biologics Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 133. NorthX Biologics Recombinant Protein Production Service Product Portfolio
Table 134. NorthX Biologics Recent Developments
Table 135. Jubilant Biosys Company Information
Table 136. Jubilant Biosys Business Overview
Table 137. Jubilant Biosys Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 138. Jubilant Biosys Recombinant Protein Production Service Product Portfolio
Table 139. Jubilant Biosys Recent Developments
Table 140. GenScript Company Information
Table 141. GenScript Business Overview
Table 142. GenScript Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 143. GenScript Recombinant Protein Production Service Product Portfolio
Table 144. GenScript Recent Developments
Table 145. Boster Bio Company Information
Table 146. Boster Bio Business Overview
Table 147. Boster Bio Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 148. Boster Bio Recombinant Protein Production Service Product Portfolio
Table 149. Boster Bio Recent Developments
Table 150. Sino Biological Company Information
Table 151. Sino Biological Business Overview
Table 152. Sino Biological Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 153. Sino Biological Recombinant Protein Production Service Product Portfolio
Table 154. Sino Biological Recent Developments
Table 155. WuXi Biologic Company Information
Table 156. WuXi Biologic Business Overview
Table 157. WuXi Biologic Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 158. WuXi Biologic Recombinant Protein Production Service Product Portfolio
Table 159. WuXi Biologic Recent Developments
Table 160. CUSABIO TECHNOLOGY Company Information
Table 161. CUSABIO TECHNOLOGY Business Overview
Table 162. CUSABIO TECHNOLOGY Revenue in Recombinant Protein Production Service Business (2021-2026) & (US$ Million)
Table 163. CUSABIO TECHNOLOGY Recombinant Protein Production Service Product Portfolio
Table 164. CUSABIO TECHNOLOGY Recent Developments
Table 165. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Recombinant Protein Production Service Product Image
Figure 5. Global Recombinant Protein Production Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Recombinant Protein Production Service Market Share by Type: 2025 VS 2032
Figure 7. Mammalian Cell Based Product
Figure 8. Bacteria Based Product
Figure 9. Insect Cell Based Product
Figure 10. Others Product
Figure 11. Global Recombinant Protein Production Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Recombinant Protein Production Service Market Share by Application: 2025 VS 2032
Figure 13. Biomedicine Product
Figure 14. Industrial Biotechnology Product
Figure 15. Therapeutics Product
Figure 16. Others Product
Figure 17. Global Recombinant Protein Production Service Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 18. Global Recombinant Protein Production Service Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 19. Global Recombinant Protein Production Service Market Share by Region: 2025 VS 2032
Figure 20. Global Recombinant Protein Production Service Market Share by Players in 2025
Figure 21. Global Recombinant Protein Production Service Manufacturers Established Date
Figure 22. Global Top 5 and 10 Recombinant Protein Production Service Players Market Share by Revenue in 2025
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. North America Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. North America Recombinant Protein Production Service Market Share by Country (2021-2032)
Figure 26. United States Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Canada Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Mexico Recombinant Protein Production Service Market Share by Country (2021-2032)
Figure 29. Europe Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Europe Recombinant Protein Production Service Market Share by Country (2021-2032)
Figure 31. Germany Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. France Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. U.K. Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Italy Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Spain Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Russia Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Netherlands Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Nordic Countries Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Recombinant Protein Production Service Market Share by Country (2021-2032)
Figure 41. China Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Japan Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. South Korea Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Recombinant Protein Production Service Market Share by Country (2021-2032)
Figure 46. Australia Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. China Taiwan Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Recombinant Protein Production Service Market Share by Country (2021-2032)
Figure 51. Brazil Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Argentina Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Chile Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Colombia Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Peru Recombinant Protein Production Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Charles River Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 57. Biomatik Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 58. R&D Systems Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 59. Applied Biological Materials Inc. (abm) Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 60. VectorBuilder Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 61. BiologicsCorp Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 62. Proteos Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 63. RayBiotech Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 64. Leinco Technologies Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 65. Kinexus Bioinformatics Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 66. InVivo BioTech Services GmbH Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 67. Expression Systems Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 68. Creative Biolabs Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 69. G &P Biosciences Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 70. Eurofins Discovery Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 71. Levprot Bioscience Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 72. eEnzyme Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 73. NorthX Biologics Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 74. Jubilant Biosys Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 75. GenScript Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 76. Boster Bio Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 77. Sino Biological Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 78. WuXi Biologic Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Figure 79. CUSABIO TECHNOLOGY Revenue Growth Rate in Recombinant Protein Production Service Business (2021-2026)
Scope & coverage.
Types
- Mammalian Cell Based
- Bacteria Based
- Insect Cell Based
- Others
Applications
- Biomedicine
- Industrial Biotechnology
- Therapeutics
- Others
Companies covered
- Charles River
- Biomatik
- R&D Systems
- Applied Biological Materials Inc. (abm)
- VectorBuilder
- BiologicsCorp
- Proteos
- RayBiotech
- Leinco Technologies
- Kinexus Bioinformatics
- InVivo BioTech Services GmbH
- Expression Systems
- Creative Biolabs
- G &P Biosciences
- Eurofins Discovery
- Levprot Bioscience
- eEnzyme
- NorthX Biologics
- Jubilant Biosys
- GenScript
- Boster Bio
- Sino Biological
- WuXi Biologic
- CUSABIO TECHNOLOGY
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Recombinant Protein Production Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Mammalian Cell Based
- 2.2.3 Bacteria Based
- 2.2.4 Insect Cell Based
- 2.2.5 Others
- 2.3 Recombinant Protein Production Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biomedicine
- 2.3.3 Industrial Biotechnology
- 2.3.4 Therapeutics
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Recombinant Protein Production Service Breakdown Data by Type
- 3.1 Global Recombinant Protein Production Service Historic Market Size by Type (2021-2026)
- 3.2 Global Recombinant Protein Production Service Forecasted Market Size by Type (2027-2032)
4 Recombinant Protein Production Service Breakdown Data by Application
- 4.1 Global Recombinant Protein Production Service Historic Market Size by Application (2021-2026)
- 4.2 Global Recombinant Protein Production Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Recombinant Protein Production Service Market Perspective (2021-2032)
- 5.2 Global Recombinant Protein Production Service Growth Trends by Region
- 5.2.1 Global Recombinant Protein Production Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Recombinant Protein Production Service Historic Market Size by Region (2021-2026)
- 5.2.3 Recombinant Protein Production Service Forecasted Market Size by Region (2027-2032)
- 5.3 Recombinant Protein Production Service Market Dynamics
- 5.3.1 Recombinant Protein Production Service Industry Trends
- 5.3.2 Recombinant Protein Production Service Market Drivers
- 5.3.3 Recombinant Protein Production Service Market Challenges
- 5.3.4 Recombinant Protein Production Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Recombinant Protein Production Service Players by Revenue
- 6.1.1 Global Top Recombinant Protein Production Service Players by Revenue (2021-2026)
- 6.1.2 Global Recombinant Protein Production Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Recombinant Protein Production Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Recombinant Protein Production Service Head Office and Area Served
- 6.4 Global Recombinant Protein Production Service Players, Product Type & Application
- 6.5 Global Recombinant Protein Production Service Manufacturers Established Date
- 6.6 Global Recombinant Protein Production Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Recombinant Protein Production Service Market Size (2021-2032)
- 7.2 North America Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Recombinant Protein Production Service Market Size by Country (2021-2026)
- 7.4 North America Recombinant Protein Production Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Recombinant Protein Production Service Market Size (2021-2032)
- 8.2 Europe Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Recombinant Protein Production Service Market Size by Country (2021-2026)
- 8.4 Europe Recombinant Protein Production Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Recombinant Protein Production Service Market Size (2021-2032)
- 9.2 Asia-Pacific Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Recombinant Protein Production Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Recombinant Protein Production Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Recombinant Protein Production Service Market Size (2021-2032)
- 10.2 South America Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Recombinant Protein Production Service Market Size by Country (2021-2026)
- 10.4 South America Recombinant Protein Production Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Recombinant Protein Production Service Market Size (2021-2032)
- 11.2 Middle East & Africa Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Recombinant Protein Production Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Recombinant Protein Production Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River
- 12.1.1 Charles River Company Information
- 12.1.2 Charles River Business Overview
- 12.1.3 Charles River Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.1.4 Charles River Recombinant Protein Production Service Product Portfolio
- 12.1.5 Charles River Recent Developments
- 12.2 Biomatik
- 12.2.1 Biomatik Company Information
- 12.2.2 Biomatik Business Overview
- 12.2.3 Biomatik Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.2.4 Biomatik Recombinant Protein Production Service Product Portfolio
- 12.2.5 Biomatik Recent Developments
- 12.3 R&D Systems
- 12.3.1 R&D Systems Company Information
- 12.3.2 R&D Systems Business Overview
- 12.3.3 R&D Systems Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.3.4 R&D Systems Recombinant Protein Production Service Product Portfolio
- 12.3.5 R&D Systems Recent Developments
- 12.4 Applied Biological Materials Inc. (abm)
- 12.4.1 Applied Biological Materials Inc. (abm) Company Information
- 12.4.2 Applied Biological Materials Inc. (abm) Business Overview
- 12.4.3 Applied Biological Materials Inc. (abm) Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.4.4 Applied Biological Materials Inc. (abm) Recombinant Protein Production Service Product Portfolio
- 12.4.5 Applied Biological Materials Inc. (abm) Recent Developments
- 12.5 VectorBuilder
- 12.5.1 VectorBuilder Company Information
- 12.5.2 VectorBuilder Business Overview
- 12.5.3 VectorBuilder Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.5.4 VectorBuilder Recombinant Protein Production Service Product Portfolio
- 12.5.5 VectorBuilder Recent Developments
- 12.6 BiologicsCorp
- 12.6.1 BiologicsCorp Company Information
- 12.6.2 BiologicsCorp Business Overview
- 12.6.3 BiologicsCorp Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.6.4 BiologicsCorp Recombinant Protein Production Service Product Portfolio
- 12.6.5 BiologicsCorp Recent Developments
- 12.7 Proteos
- 12.7.1 Proteos Company Information
- 12.7.2 Proteos Business Overview
- 12.7.3 Proteos Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.7.4 Proteos Recombinant Protein Production Service Product Portfolio
- 12.7.5 Proteos Recent Developments
- 12.8 RayBiotech
- 12.8.1 RayBiotech Company Information
- 12.8.2 RayBiotech Business Overview
- 12.8.3 RayBiotech Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.8.4 RayBiotech Recombinant Protein Production Service Product Portfolio
- 12.8.5 RayBiotech Recent Developments
- 12.9 Leinco Technologies
- 12.9.1 Leinco Technologies Company Information
- 12.9.2 Leinco Technologies Business Overview
- 12.9.3 Leinco Technologies Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.9.4 Leinco Technologies Recombinant Protein Production Service Product Portfolio
- 12.9.5 Leinco Technologies Recent Developments
- 12.10 Kinexus Bioinformatics
- 12.10.1 Kinexus Bioinformatics Company Information
- 12.10.2 Kinexus Bioinformatics Business Overview
- 12.10.3 Kinexus Bioinformatics Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.10.4 Kinexus Bioinformatics Recombinant Protein Production Service Product Portfolio
- 12.10.5 Kinexus Bioinformatics Recent Developments
- 12.11 InVivo BioTech Services GmbH
- 12.11.1 InVivo BioTech Services GmbH Company Information
- 12.11.2 InVivo BioTech Services GmbH Business Overview
- 12.11.3 InVivo BioTech Services GmbH Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.11.4 InVivo BioTech Services GmbH Recombinant Protein Production Service Product Portfolio
- 12.11.5 InVivo BioTech Services GmbH Recent Developments
- 12.12 Expression Systems
- 12.12.1 Expression Systems Company Information
- 12.12.2 Expression Systems Business Overview
- 12.12.3 Expression Systems Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.12.4 Expression Systems Recombinant Protein Production Service Product Portfolio
- 12.12.5 Expression Systems Recent Developments
- 12.13 Creative Biolabs
- 12.13.1 Creative Biolabs Company Information
- 12.13.2 Creative Biolabs Business Overview
- 12.13.3 Creative Biolabs Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.13.4 Creative Biolabs Recombinant Protein Production Service Product Portfolio
- 12.13.5 Creative Biolabs Recent Developments
- 12.14 G &P Biosciences
- 12.14.1 G &P Biosciences Company Information
- 12.14.2 G &P Biosciences Business Overview
- 12.14.3 G &P Biosciences Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.14.4 G &P Biosciences Recombinant Protein Production Service Product Portfolio
- 12.14.5 G &P Biosciences Recent Developments
- 12.15 Eurofins Discovery
- 12.15.1 Eurofins Discovery Company Information
- 12.15.2 Eurofins Discovery Business Overview
- 12.15.3 Eurofins Discovery Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.15.4 Eurofins Discovery Recombinant Protein Production Service Product Portfolio
- 12.15.5 Eurofins Discovery Recent Developments
- 12.16 Levprot Bioscience
- 12.16.1 Levprot Bioscience Company Information
- 12.16.2 Levprot Bioscience Business Overview
- 12.16.3 Levprot Bioscience Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.16.4 Levprot Bioscience Recombinant Protein Production Service Product Portfolio
- 12.16.5 Levprot Bioscience Recent Developments
- 12.17 eEnzyme
- 12.17.1 eEnzyme Company Information
- 12.17.2 eEnzyme Business Overview
- 12.17.3 eEnzyme Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.17.4 eEnzyme Recombinant Protein Production Service Product Portfolio
- 12.17.5 eEnzyme Recent Developments
- 12.18 NorthX Biologics
- 12.18.1 NorthX Biologics Company Information
- 12.18.2 NorthX Biologics Business Overview
- 12.18.3 NorthX Biologics Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.18.4 NorthX Biologics Recombinant Protein Production Service Product Portfolio
- 12.18.5 NorthX Biologics Recent Developments
- 12.19 Jubilant Biosys
- 12.19.1 Jubilant Biosys Company Information
- 12.19.2 Jubilant Biosys Business Overview
- 12.19.3 Jubilant Biosys Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.19.4 Jubilant Biosys Recombinant Protein Production Service Product Portfolio
- 12.19.5 Jubilant Biosys Recent Developments
- 12.20 GenScript
- 12.20.1 GenScript Company Information
- 12.20.2 GenScript Business Overview
- 12.20.3 GenScript Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.20.4 GenScript Recombinant Protein Production Service Product Portfolio
- 12.20.5 GenScript Recent Developments
- 12.21 Boster Bio
- 12.21.1 Boster Bio Company Information
- 12.21.2 Boster Bio Business Overview
- 12.21.3 Boster Bio Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.21.4 Boster Bio Recombinant Protein Production Service Product Portfolio
- 12.21.5 Boster Bio Recent Developments
- 12.22 Sino Biological
- 12.22.1 Sino Biological Company Information
- 12.22.2 Sino Biological Business Overview
- 12.22.3 Sino Biological Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.22.4 Sino Biological Recombinant Protein Production Service Product Portfolio
- 12.22.5 Sino Biological Recent Developments
- 12.23 WuXi Biologic
- 12.23.1 WuXi Biologic Company Information
- 12.23.2 WuXi Biologic Business Overview
- 12.23.3 WuXi Biologic Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.23.4 WuXi Biologic Recombinant Protein Production Service Product Portfolio
- 12.23.5 WuXi Biologic Recent Developments
- 12.24 CUSABIO TECHNOLOGY
- 12.24.1 CUSABIO TECHNOLOGY Company Information
- 12.24.2 CUSABIO TECHNOLOGY Business Overview
- 12.24.3 CUSABIO TECHNOLOGY Revenue in Recombinant Protein Production Service Business (2021-2026)
- 12.24.4 CUSABIO TECHNOLOGY Recombinant Protein Production Service Product Portfolio
- 12.24.5 CUSABIO TECHNOLOGY Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst